BrainsWay Ltd. Industries
-
Clinical Services
-
-
-
-
-
-
-
-
-
A revolutionary depression treatment that has changed the field of mental healthcare, Deep TMS has been FDA-cleared to safely and effectively treat Major Depressive Disorder through BrainsWay’s patented H-coil technology.
Deep Transcranial Magnetic Stimulation (Deep TMS™) is the only TMS system FDA-cleared to safely and effectively reduce comorbid anxiety symptoms in adult patients with depression, also known as anxious depression.
Deep Transcranial Magnetic Stimulation, or Deep TMS, has been shown to safely and effectively alleviate the symptoms of obsessive-compulsive disorder (OCD), particularly those patients who have not achieved sufficient improvement from traditional OCD treatment options.
BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) is a safe and effective aid for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS device.
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in a person’s mood, energy, and ability to function. Different from the normal ups and downs that everyone goes through, the symptoms of bipolar disorder are severe. They can result in damaged relationships, poor job or school performance, and even suicide. About 5.7 million American adults or about 2.6 percent of the population aged 18 and older in any given year, have bipolar disorder.
Post-traumatic stress disorder (PTSD) is an extreme anxiety response to a life-threatening situation, which often manifests as a tendency to avoid places or events that could remind patients of the traumatic experience, and which may impair patients’ quality of life for years, as well as their ability to function normally in daily life.
Anti-psychotic medications are often effective for the positive symptoms of schizophrenia, and allow many patients to lead normal lives. However, many patients suffer from negative symptoms, which include inexpressiveness, deficits in cognitive and emotional skills, and lethargy. To date, the FDA has not approved any drug for the treatment of the negative symptoms of schizophrenia, and from the clinical data available it does not appear as though existing drugs – even new generation drugs – represent...
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term memory.
Autism is a complex developmental disability that typically appears during the first three years of life and is the result of a neurological disorder that affects the normal functioning of the brain. Autism is characterized by three kinds of symptoms: deficiency in social interaction, difficulties in verbal and non-verbal communication, and severe disabilities in interest areas and activities. In addition, autistic people may develop extreme reactions to noise, touch, or other sensory stimuli. These symptoms...